Hamilton Anxiety Rating Scale Questionnaire

Known as: HAMA, HAM-A, HAMA1 
A standardized rating scale developed by M. Hamilton in 1959 which is used to evaluate the severity of an individual's state of neurotic anxiety… (More)
National Institutes of Health

Related topics

Related topics

2 relations
CDISC Clinical Classification Category TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Interventions for treating anxiety after stroke.
BACKGROUND Approximately 20% of stroke patients experience clinically significant levels of anxiety at some point after stroke… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity.
OBJECTIVE Mindfulness meditation has met increasing interest as a therapeutic strategy for anxiety disorders, but prior studies… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2009
2009
Exploiting heterogeneity in grid computing for energy-efficient resource allocation
The growing computing demand from industry and academia has lead to excessive power consumption which not only impacting long… (More)
  • figure 1
  • table I
  • table II
  • figure 2
  • figure 3
Is this relevant?
2008
2008
Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
Generalized anxiety disorder (GAD) is a highly prevalent and disabling condition. Escitalopram and venlafaxine extended release… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
BACKGROUND Pregabalin inhibits release of excess excitatory neurotransmitters, presumably by binding to the alpha2-delta subunit… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2004
2004
The Change of Regional Brain Metabolism (18 FDG PET) in Panic Disorder During The Treatment with Cognitive Behavioral Therapy or Antidepressants
BACKGROUND The goal of our study was to identify brain structures in patients with panic disorder (PD) that show changes in 18FDG… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 4
Is this relevant?
2004
2004
Does comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic study.
The aim of this study was to evaluate the effects of comorbid subthreshold anxiety on the course and the treatment of Depressive… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
BACKGROUND The objective of this randomized, double-blind, placebo-controlled study was to investigate the efficacy and safety of… (More)
Is this relevant?
2000
2000
[Acupuncture in patients with minor depressive episodes and generalized anxiety. Results of an experimental study].
In a placebo-controlled, randomized, modified double-blind study we investigated the effects of body needle acupuncture (n = 10… (More)
Is this relevant?
1993
1993
Vegetation patterns in relation to micro-scale landforms in hilly land regions
Spatial structures of landforms as constants affecting vegetation patterns are discussed based on analyses of hilly land regions… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?